Anti-ICOS/CD278 Antibody (Vopratelimab)
Catalog No.
F1505
Anti-ICOS/CD278 Antibody (Vopratelimab)
Featured Products
Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that specifically binds to inducible T-cell CO stimulator (ICOS). Vopratelimab retains species cross-reactivity with an affinity of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS. Vopratelimab has an anti-tumor immune response.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.8 kDa
Dry ice
2039148-04-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
JTX-2011, vopra
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9Y6W8
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ICOS / CD278
Please avoid freeze-thaw cycles.